Columbia University Irving Medical Center, New York, New York (M.R.A., J.G., J.Z., Y.R.N., D.F., J.S., K.N.R., S.C., K.N., D.R., E.E., A.P., A.W.F., M.R.B.).
Villanova School of Business, Villanova University, Villanova, Pennsylvania (D.R.A.).
Ann Intern Med. 2020 Nov 17;173(10):782-790. doi: 10.7326/M20-3214. Epub 2020 Jul 29.
Obesity is a risk factor for pneumonia and acute respiratory distress syndrome.
To determine whether obesity is associated with intubation or death, inflammation, cardiac injury, or fibrinolysis in coronavirus disease 2019 (COVID-19).
Retrospective cohort study.
A quaternary academic medical center and community hospital in New York City.
2466 adults hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection over a 45-day period with at least 47 days of in-hospital observation.
Body mass index (BMI), admission biomarkers of inflammation (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), cardiac injury (troponin level), and fibrinolysis (D-dimer level). The primary end point was a composite of intubation or death in time-to-event analysis.
Over a median hospital length of stay of 7 days (interquartile range, 3 to 14 days), 533 patients (22%) were intubated, 627 (25%) died, and 59 (2%) remained hospitalized. Compared with overweight patients, patients with obesity had higher risk for intubation or death, with the highest risk among those with class 3 obesity (hazard ratio, 1.6 [95% CI, 1.1 to 2.1]). This association was primarily observed among patients younger than 65 years and not in older patients ( for interaction by age = 0.042). Body mass index was not associated with admission levels of biomarkers of inflammation, cardiac injury, or fibrinolysis.
Body mass index was missing for 28% of patients. The primary analyses were conducted with multiple imputation for missing BMI. Upper bounding factor analysis suggested that the results are robust to possible selection bias.
Obesity is associated with increased risk for intubation or death from COVID-19 in adults younger than 65 years, but not in adults aged 65 years or older.
National Institutes of Health.
肥胖是肺炎和急性呼吸窘迫综合征的一个危险因素。
确定肥胖是否与 2019 年冠状病毒病(COVID-19)患者的插管或死亡、炎症、心脏损伤或纤维蛋白溶解有关。
回顾性队列研究。
纽约市的一家四级学术医疗中心和社区医院。
在 45 天的时间内,有 2466 名成年人因实验室确诊的严重急性呼吸综合征冠状病毒 2 感染住院,至少有 47 天的住院观察。
体重指数(BMI)、入院时炎症的生物标志物(C 反应蛋白[CRP]水平和红细胞沉降率[ESR])、心脏损伤(肌钙蛋白水平)和纤维蛋白溶解(D-二聚体水平)。主要终点是时间事件分析中的插管或死亡复合终点。
在中位住院时间为 7 天(四分位间距,3 至 14 天)期间,533 名患者(22%)需要插管,627 名患者(25%)死亡,59 名患者(2%)仍住院。与超重患者相比,肥胖患者插管或死亡的风险更高,3 级肥胖患者的风险最高(风险比,1.6[95%CI,1.1 至 2.1])。这种关联主要见于 65 岁以下的患者,而不是 65 岁以上的患者(年龄交互检验=0.042)。BMI 与入院时炎症、心脏损伤或纤维蛋白溶解的生物标志物水平无关。
28%的患者 BMI 缺失。主要分析是对缺失 BMI 进行多重插补。上限因子分析表明,结果对可能的选择偏倚具有稳健性。
在 65 岁以下的成年人中,肥胖与 COVID-19 插管或死亡的风险增加相关,但在 65 岁及以上的成年人中则不相关。
美国国立卫生研究院。